Imaging Neuroendocrine Prostate Cancer with ⁸⁹Zr-labeled Delta-Like Ligand 3

HomeRadiology: Imaging CancerVol. 5, No. 1 PreviousNext Research HighlightsImaging Neuroendocrine Prostate Cancer with 89Zr-labeled Delta-Like Ligand 3Kel Vin TanKel Vin TanKel Vin TanPublished Online:Jan 20 2023https://doi.org/10.1148/rycan.239002MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In Highlighted ArticleKorsen JA, Kalidindi TM, Khitrov S, et al. Molecular imaging of neuroendocrine prostate cancer by targeting delta-like ligand 3. J Nucl Med 2022;63(9):1401–1407.doi: https://doi.org/10.2967/jnumed.121.263221 Crossref, Medline, Google ScholarArticle HistoryPublished online: Jan 20 2023 FiguresReferencesRelatedDetailsRecommended Articles RSNA Education Exhibits RSNA Case Collection Vol. 5, No. 1 Metrics Altmetric Score PDF download